Buyer Mistakes · Telehealth Platform

6 Mistakes That Destroy Value When Acquiring a Telehealth Platform

From hidden HIPAA liability to reimbursement cliffs, here's what experienced buyers know before signing on a digital health deal.

Find Vetted Telehealth Platform Deals

Telehealth platforms trade at 3.5x–6x revenue, but buyers regularly overpay or inherit catastrophic liability by skipping healthcare-specific diligence. These six mistakes account for the majority of failed or underperforming telehealth acquisitions in the lower middle market.

Common Mistakes When Buying a Telehealth Platform Business

critical

Ignoring HIPAA Liability in Legacy Codebases

Buyers assume HIPAA compliance from a seller's verbal assurance. Unaudited legacy code can harbor serious data security gaps creating OCR investigation exposure and multi-million dollar breach liability post-close.

How to avoid: Require a third-party HIPAA security risk assessment completed within 12 months. Review all BAA agreements and confirm audit logs, encryption standards, and access controls meet current OCR guidance.

critical

Underestimating Reimbursement Policy Risk

Federal telehealth flexibilities granted during COVID-19 face periodic expiration. Revenue built on emergency-use reimbursement codes can evaporate with a single CMS policy change, making historical ARR misleading.

How to avoid: Map every revenue stream to specific CPT and reimbursement codes. Identify what percentage depends on temporary telehealth waivers and model a downside scenario assuming those waivers expire at close.

critical

Overlooking Customer Revenue Concentration

Many lower middle market telehealth platforms derive 40–60% of revenue from a single health system or employer client. Losing that contract post-acquisition can immediately impair the business's valuation basis.

How to avoid: Require a full customer cohort analysis before LOI. Insist on contract assignment clauses and consider earnout structures that defer payment until key client relationships survive transition under new ownership.

major

Skipping IP Ownership and Code Dependency Audits

Platforms built with offshore developers or open-source libraries often have incomplete IP assignment agreements. Buyers can acquire a product they don't legally own or that violates licensing terms at scale.

How to avoid: Engage a technical counsel to audit all IP assignment agreements, contractor contracts, and open-source license dependencies before close. Confirm the legal entity owns all proprietary code and clinical algorithms outright.

major

Accepting Founder-Dependent Clinical Operations

When payer relationships, provider credentialing, or platform access are tied personally to the founder, transition risk is severe. Buyers often discover this dependency only after the seller has exited.

How to avoid: Require a 6–12 month transition agreement and verify that contracts, provider network agreements, and login credentials are held by the company entity, not the individual founder.

major

Misreading EHR Integration Complexity and Tech Debt

Buyers assume existing EHR integrations are portable and scalable. In reality, custom API builds are often brittle, poorly documented, and require expensive re-engineering when merging with acquirer systems.

How to avoid: Commission a third-party technical architecture review. Request a vendor dependency map and integration documentation. Budget conservatively for re-platforming costs before finalizing your offer price.

Warning Signs During Telehealth Platform Due Diligence

  • Seller cannot produce a completed third-party HIPAA security risk assessment from the past 18 months
  • More than 40% of ARR tied to a single health system, employer, or payer contract expiring within 24 months
  • Revenue growth primarily attributable to COVID-era telehealth waivers with no diversified payer mix
  • Source code repository shows significant contributions from offshore contractors without IP assignment agreements on file
  • Founder holds personal provider credentials or payer relationships not transferable to the acquiring entity

Frequently Asked Questions

Is telehealth platform acquisition SBA-eligible?

No. Telehealth platforms are generally not SBA-eligible due to passive income characteristics and healthcare licensing complexity. Most deals are structured with private capital, earnouts, or equity rollovers.

What gross margin should I require before acquiring a telehealth platform?

Target platforms with 70% or higher gross margins. Margins below this threshold often signal high provider labor costs, unsustainable reimbursement rates, or significant third-party infrastructure dependency requiring renegotiation.

How do I evaluate reimbursement sustainability before closing?

Map all revenue to specific CPT codes and payer contracts. Identify COVID-era waiver dependencies, review multi-year payer agreements, and consult a healthcare reimbursement attorney to stress-test policy change scenarios.

What deal structure best protects buyers in telehealth acquisitions?

Earnouts tied to post-close ARR milestones over 12–24 months reduce overpayment risk from reimbursement changes. Equity rollovers of 15–30% with the seller as clinical advisor help preserve provider relationships during transition.

More Telehealth Platform Guides

Find Telehealth Platform deals the right way

DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.

Start finding deals — free

No credit card required